TRI inks funding
UK and Raleigh, North Carolina-based TRI, a provider of risk-based monitoring solutions for clinical trials, has raised an undisclosed amount of funding. The investor was Octopus Investments, a subsidiary of the Octopus Group.
15 October 2018•1 min read
